- Nasdaq Listing Qualifications department notified Sesen Bio ( NASDAQ: SESN ) that it has been granted a second 180-day grace period, or until Jan.23, 2023 for regaining compliance with the minimum bid price requirement.
- In January, the company had received its non-compliance letter and was granted time until July 25, 2022, to regain compliance with the minimum bid price requirement.
- The stock will be transferred to the Nasdaq Capital Market effective July 28, 2022 and will continue to trade under the current symbol.
- Shares trading 2% down premarket
For further details see:
Sesen Bio granted additional time period for regaining compliance